VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,237,478 | -10.6% | 1,160,813 | 0.0% | 3.12% | -25.7% |
Q2 2023 | $34,952,079 | +81.3% | 1,160,813 | +94.8% | 4.20% | +75.3% |
Q1 2023 | $19,274,551 | +7.8% | 595,813 | -4.5% | 2.40% | +2.3% |
Q4 2022 | $17,886,505 | +18.8% | 624,093 | 0.0% | 2.34% | +34.0% |
Q3 2022 | $15,053,000 | -70.6% | 624,093 | -66.7% | 1.75% | -4.7% |
Q2 2022 | $51,261,000 | +114.2% | 1,872,279 | +200.0% | 1.84% | +11.0% |
Q1 2022 | $23,934,000 | +19.7% | 624,093 | 0.0% | 1.66% | +31.9% |
Q4 2021 | $19,990,000 | +58.1% | 624,093 | +45.4% | 1.26% | +73.6% |
Q3 2021 | $12,646,000 | -12.8% | 429,093 | +0.6% | 0.72% | -10.3% |
Q2 2021 | $14,500,000 | +85.1% | 426,717 | +113.4% | 0.81% | -22.2% |
Q3 2020 | $7,832,000 | -45.2% | 200,000 | -48.7% | 1.04% | +18.7% |
Q2 2020 | $14,286,000 | +327.6% | 389,500 | +168.6% | 0.87% | +254.9% |
Q1 2020 | $3,341,000 | -20.2% | 145,000 | +1.4% | 0.25% | +25.5% |
Q4 2019 | $4,187,000 | – | 143,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |